Academic Journal
29LBA Entrectinib (RXDX-101), an oral pan-Trk, ROS1, and ALK inhibitor in patients with advanced solid tumors harboring gene rearrangements
العنوان: | 29LBA Entrectinib (RXDX-101), an oral pan-Trk, ROS1, and ALK inhibitor in patients with advanced solid tumors harboring gene rearrangements |
---|---|
المؤلفون: | Siena, S., Drilon, A.E., Sai-Hong Ou, I., Farago, A.F., Patel, M., Bauer, T.M., Hong, D., Liu, S.V., Lee, J., Patel, R., Schechet, L., Luo, D., Chow Maneval, E., Multani, P.S., De Braud, F.G. |
المصدر: | European Journal of Cancer ; volume 51, page S724-S725 ; ISSN 0959-8049 |
بيانات النشر: | Elsevier BV |
سنة النشر: | 2015 |
المجموعة: | ScienceDirect (Elsevier - Open Access Articles via Crossref) |
نوع الوثيقة: | article in journal/newspaper |
اللغة: | English |
DOI: | 10.1016/s0959-8049(16)31947-5 |
الاتاحة: | http://dx.doi.org/10.1016/s0959-8049(16)31947-5 https://api.elsevier.com/content/article/PII:S0959804916319475?httpAccept=text/xml https://api.elsevier.com/content/article/PII:S0959804916319475?httpAccept=text/plain |
Rights: | https://www.elsevier.com/tdm/userlicense/1.0/ |
رقم الانضمام: | edsbas.8628BECF |
قاعدة البيانات: | BASE |
DOI: | 10.1016/s0959-8049(16)31947-5 |
---|